SLRX

Salarius Pharmaceuticals Stock Price

1.45
0.01 (0.69%)
Upgrade to Real-Time
Afterhours (Closed)
1.44
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Salarius Pharmaceuticals Inc SLRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.06 4.35% 1.44 1.39 1.46 1.45 1.38 20:00:00
Bid Price Ask Price Spread Spread % News
1.45 1.52 0.07 4.61% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
738 198,723 $ 1.43 $ 284,731 1,137,319 0.13 - 14.8154
Last Trade Time Type Quantity Stock Price Currency
18:11:08 3 $ 1.45 USD

Salarius Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 19.66M 13.65M 13.14M $ 2.18M $ - -6.17 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Salarius Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SLRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.311.471.251.34270,4580.139.92%
1 Month1.171.951.151.57723,9090.2723.08%
3 Months0.681.950.131.22732,9860.76111.76%
6 Months3.753.950.131.16486,716-2.31-61.6%
1 Year11.5514.81540.131.55285,432-10.11-87.53%
3 Years11.5514.81540.131.55285,432-10.11-87.53%
5 Years11.5514.81540.131.55285,432-10.11-87.53%

Salarius Pharmaceuticals Description

Salarius Pharmaceuticals Inc is a biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. Its lead compound Seclidemstat is in clinical development for treating Ewing sarcoma.


Your Recent History
NASDAQ
SLRX
Salarius P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.